Clinical Takeaway Clinical Takeaway This phase 3 trial demonstrated that VER-01, a full-spectrum cannabis extract, provided meaningful pain reduction in chronic low back pain patients over 12 weeks compared to placebo, with...
Tirzepatide vs Liraglutide: Clinical Evidence & Research
GLP-1 Clinical Relevance #43Contextual Information Background context; limited direct clinical applicability. โ GLP-1 News | CED Clinic Clinical TrialPhase 3 RCTType 2 DiabetesTirzepatidePrimary CareAdults with ObesityHbA1c ReductionGlucose HomeostasisGLP-1 Receptor AgonistDual GIP-GLP-1 AgonistSURMOUNT...
GLP-1 Receptor Agonist Clinical Evidence: Semaglutide Efficacy
GLP-1 Clinical Relevance #48Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. โ GLP-1 News | CED Clinic Clinical TrialPhase 3 RCTType 2 DiabetesSemaglutideEndocrinologyAdults with Type 2 DiabetesGlycemic ControlGLP-1 Receptor...
AM Study Update: March 17, 2026
AM Study UpdateMarch 17, 2026. 20 cannabis research items from PubMed, sorted by clinical priority. Evidence Watch | Nature medicine (2025)Full-spectrum extract from Cannabis sativa DKJ127 for chronic low back pain: a...
AM Study Update: March 16, 2026
AM Study UpdateMarch 16, 2026. 20 cannabis research items from PubMed, sorted by clinical priority. Evidence Watch | Nature medicine (2025)Full-spectrum extract from Cannabis sativa DKJ127 for chronic low back pain: a...
AM Study Update: March 15, 2026
AM Study UpdateMarch 15, 2026. 20 cannabis research items from PubMed, sorted by clinical priority. Evidence Watch | Nature medicine (2025)Full-spectrum extract from Cannabis sativa DKJ127 for chronic low back pain: a...
AM Study Update: March 11, 2026
AM Study UpdateMarch 11, 2026. 20 cannabis research items from PubMed, sorted by clinical priority. Evidence Watch | Nature medicine (2025) Study Summary This phase 3 trial evaluated full-spectrum cannabis extract for...
medical cannabis evidence-based care: Phase 3 Trial Results
Clinical Takeaway In this phase 3 trial of 820 adults with chronic low back pain, the full-spectrum cannabis extract VER-01 was evaluated over a 12-week double-blind treatment period with extensions up to...